Literature DB >> 15459341

Peroxidative aggregation of alpha-synuclein requires tyrosines.

Alina Olteanu1, Gary J Pielak.   

Abstract

Alpha-synuclein is the main component of the intracellular protein aggregates in neurons of patients with Parkinson's disease. The occurrence of the disease is associated with oxidative damage. Although it is known that peroxidative chemistry leads to the aggregation of alpha-synuclein in vitro, the specific amino acid types of alpha-synuclein involved in this type of aggregation have not been identified. We show, using human cytochrome c plus H(2)O(2) as the source oxidative stress, that the tyrosines of alpha-synuclein are required for aggregation. The studies reveal the chemical basis for a crucial step in the aggregation process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459341      PMCID: PMC2286587          DOI: 10.1110/ps.04947204

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  32 in total

1.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

Authors:  P H Weinreb; W Zhen; A W Poon; K A Conway; P T Lansbury
Journal:  Biochemistry       Date:  1996-10-29       Impact factor: 3.162

2.  Characterization of cytochrome c free radical reactions with peptides by mass spectrometry.

Authors:  L J Deterding; D P Barr; R P Mason; K B Tomer
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

Review 3.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

Review 4.  Protein oxidation in aging, disease, and oxidative stress.

Authors:  B S Berlett; E R Stadtman
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

5.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

6.  Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.

Authors:  M Hashimoto; A Takeda; L J Hsu; T Takenouchi; E Masliah
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

7.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

8.  Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.

Authors:  S Pennathur; V Jackson-Lewis; S Przedborski; J W Heinecke
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

9.  Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

Authors:  W S Davidson; A Jonas; D F Clayton; J M George
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

10.  ESR spin-trapping of a protein-derived tyrosyl radical from the reaction of cytochrome c with hydrogen peroxide.

Authors:  D P Barr; M R Gunther; L J Deterding; K B Tomer; R P Mason
Journal:  J Biol Chem       Date:  1996-06-28       Impact factor: 5.157

View more
  7 in total

1.  Alpha-Synuclein conformation affects its tyrosine-dependent oxidative aggregation.

Authors:  Rebecca A S Ruf; Evan A Lutz; Imola G Zigoneanu; Gary J Pielak
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

2.  Laser-induced propagation and destruction of amyloid beta fibrils.

Authors:  Hisashi Yagi; Daisaku Ozawa; Kazumasa Sakurai; Toru Kawakami; Hiroki Kuyama; Osamu Nishimura; Toshinori Shimanouchi; Ryoichi Kuboi; Hironobu Naiki; Yuji Goto
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

Review 3.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

4.  Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease.

Authors:  Hülya Bayir; Alexandr A Kapralov; Janfei Jiang; Zhentai Huang; Yulia Y Tyurina; Vladimir A Tyurin; Qing Zhao; Natalia A Belikova; Irina I Vlasova; Akihiro Maeda; Jianhui Zhu; Hye-Mee Na; Pier-Giorgio Mastroberardino; Louis J Sparvero; Andrew A Amoscato; Charleen T Chu; John T Greenamyre; Valerian E Kagan
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

5.  Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease.

Authors:  Steven R Danielson; Jason M Held; Birgit Schilling; May Oo; Bradford W Gibson; Julie K Andersen
Journal:  Anal Chem       Date:  2009-09-15       Impact factor: 6.986

6.  Role of cytochrome c in α-synuclein radical formation: implications of α-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson's disease.

Authors:  Ashutosh Kumar; Douglas Ganini; Ronald P Mason
Journal:  Mol Neurodegener       Date:  2016-11-24       Impact factor: 14.195

Review 7.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.